Stereotaxis Inc. (STXS)
Stereotaxis Inc. (STXS) Stock Price, Analysis & Data
| Bid | n/a |
| Market Cap | 135.49M |
| Revenue (ttm) | 30.07M |
| Net Income (ttm) | -23.59M |
| Beta | 1.40 |
| EPS (ttm) | -0.24 |
| PE Ratio (ttm) | n/a |
| Forward PE | -8.77 |
| P/B (ttm) | 9.25 |
| P/S (ttm) | 4.51 |
| Earnings Date | Nov 16, 2026 |
| Ask | n/a |
| Volume | 534,916 |
| Avg. Volume (20D) | 816,250 |
| Open | 1.38 |
| Previous Close | 1.39 |
| Day's Range | 1.35 - 1.40 |
| 52-Week Range | 1.24 - 3.59 |
| Analyst | Strong Buy |
| Price Target | 4 (194.12%) |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About STXS
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment s...
Financial Performance
In 2025, Stereotaxis's revenue was 32.38M, an increase of 20.28% compared to the previous year's 26.92M. Earnings were -21.64M, a decrease of -9.99%.
Financial StatementsAnalyst Forecast
According to 4 analyst ratings, the average rating for STXS stock is "Strong Buy". The 12-month stock price forecast is 4, which is upside of 194.12% from the latest price.
Stock ForecastsEarnings Surprise
Analysts project revenue of ... Upgrade
